Literature DB >> 18382740

Enteric infections, diarrhea, and their impact on function and development.

William A Petri1, Mark Miller, Henry J Binder, Myron M Levine, Rebecca Dillingham, Richard L Guerrant.   

Abstract

Enteric infections, with or without overt diarrhea, have profound effects on intestinal absorption, nutrition, and childhood development as well as on global mortality. Oral rehydration therapy has reduced the number of deaths from dehydration caused by infection with an enteric pathogen, but it has not changed the morbidity caused by such infections. This Review focuses on the interactions between enteric pathogens and human genetic determinants that alter intestinal function and inflammation and profoundly impair human health and development. We also discuss specific implications for novel approaches to interventions that are now opened by our rapidly growing molecular understanding.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18382740      PMCID: PMC2276781          DOI: 10.1172/JCI34005

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  162 in total

Review 1.  Ascariasis and childhood malnutrition.

Authors:  D W Crompton
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Nov-Dec       Impact factor: 2.184

2.  Genetic and environmental factors in the immunopathogenesis of atopy: interaction of Helicobacter pylori infection and IL4 genetics.

Authors:  T Pessi; M Virta; K Adjers; J Karjalainen; H Rautelin; T U Kosunen; M Hurme
Journal:  Int Arch Allergy Immunol       Date:  2005-06-17       Impact factor: 2.749

3.  Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults.

Authors:  L F Fries; A D Montemarano; C P Mallett; D N Taylor; T L Hale; G H Lowell
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Diarrheagenic Escherichia coli infection in Baltimore, Maryland, and New Haven, Connecticut.

Authors:  James P Nataro; Volker Mai; Judith Johnson; William C Blackwelder; Robert Heimer; Shirley Tirrell; Stephen C Edberg; Christopher R Braden; J Glenn Morris; Jon Mark Hirshon
Journal:  Clin Infect Dis       Date:  2006-07-11       Impact factor: 9.079

5.  Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers.

Authors:  B D Kirkpatrick; Robin McKenzie; J Patrick O'Neill; Catherine J Larsson; A Louis Bourgeois; Janet Shimko; Matthew Bentley; Jill Makin; Steve Chatfield; Zoë Hindle; Christine Fidler; Brad E Robinson; Cassandra H Ventrone; Nivedita Bansal; Colleen M Carpenter; Deborah Kutzko; Sandra Hamlet; Casey LaPointe; David N Taylor
Journal:  Vaccine       Date:  2005-08-18       Impact factor: 3.641

6.  Characterization of butyrate-dependent electroneutral Na-Cl absorption in the rat distal colon.

Authors:  H J Binder; P Mehta
Journal:  Pflugers Arch       Date:  1990-12       Impact factor: 3.657

7.  Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection.

Authors:  Thorsten Thye; Gerd D Burchard; Manfred Nilius; Bertram Müller-Myhsok; Rolf D Horstmann
Journal:  Am J Hum Genet       Date:  2003-01-06       Impact factor: 11.025

8.  Nerve involvement in fluid transport in the inflamed rat jejunum.

Authors:  M Jodal; U Wingren; M Jansson; M Heidemann; O Lundgren
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

9.  Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media.

Authors:  Karen L Kotloff; Jakub K Simon; Marcela F Pasetti; Marcelo B Sztein; Stacey L Wooden; Sofie Livio; James P Nataro; William C Blackwelder; Eileen M Barry; Wendy Picking; Myron M Levine
Journal:  Hum Vaccin       Date:  2007-07-15

Review 10.  Enteral and parenteral nutrition in the care of patients with short-bowel syndrome.

Authors:  Jon A Vanderhoof; Rosemary J Young
Journal:  Best Pract Res Clin Gastroenterol       Date:  2003-12       Impact factor: 3.043

View more
  156 in total

Review 1.  Secretory IgA: arresting microbial pathogens at epithelial borders.

Authors:  Nicholas J Mantis; Stephen J Forbes
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

2.  Evaluation of rapid antigen point-of-care tests for detection of Giardia and Cryptosporidium species in human fecal specimens.

Authors:  Juliana Minak; Mamun Kabir; Iqbal Mahmud; Yue Liu; Lei Liu; Rashidul Haque; William A Petri
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

3.  A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults.

Authors:  Clayton Harro; David Sack; A Louis Bourgeois; R Walker; Barbara DeNearing; Andrea Feller; Subhra Chakraborty; Charlotte Buchwaldt; Michael J Darsley
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

4.  Improving the performance of enteric vaccines in the developing world.

Authors:  Andrew C Serazin; Laura A Shackelton; Christopher Wilson; Maharaj K Bhan
Journal:  Nat Immunol       Date:  2010-09       Impact factor: 25.606

5.  Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica.

Authors:  Mayuresh M Abhyankar; Zannatun Noor; Mark A Tomai; James Elvecrog; Christopher B Fox; William A Petri
Journal:  Vaccine       Date:  2017-01-12       Impact factor: 3.641

6.  Comparative Detection and Quantification of Arcobacter butzleri in Stools from Diarrheic and Nondiarrheic People in Southwestern Alberta, Canada.

Authors:  Andrew L Webb; Valerie F Boras; Peter Kruczkiewicz; L Brent Selinger; Eduardo N Taboada; G Douglas Inglis
Journal:  J Clin Microbiol       Date:  2016-02-10       Impact factor: 5.948

7.  Study of intra-inter species protein-protein interactions for potential drug targets identification and subsequent drug design for Escherichia coli O104:H4 C277-11.

Authors:  Shakhinur Islam Mondal; Zabed Mahmud; Montasir Elahi; Arzuba Akter; Nurnabi Azad Jewel; Md Muzahidul Islam; Sabiha Ferdous; Taisei Kikuchi
Journal:  In Silico Pharmacol       Date:  2017-04-11

Review 8.  Intestinal Organoids: New Frontiers in the Study of Intestinal Disease and Physiology.

Authors:  Thomas E Wallach; James R Bayrer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

9.  Cross-Comparison of Human Wastewater-Associated Molecular Markers in Relation to Fecal Indicator Bacteria and Enteric Viruses in Recreational Beach Waters.

Authors:  B Hughes; D J Beale; P G Dennis; S Cook; W Ahmed
Journal:  Appl Environ Microbiol       Date:  2017-03-31       Impact factor: 4.792

10.  The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease.

Authors:  Michael J Darsley; Subhra Chakraborty; Barbara DeNearing; David A Sack; Andrea Feller; Charlotte Buchwaldt; A Louis Bourgeois; Richard Walker; Clayton D Harro
Journal:  Clin Vaccine Immunol       Date:  2012-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.